Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction

Circulation: Cardiovascular Quality and Outcomes

Volumn 9, Issue 2, 2016, Pages 117-125

  Goldberg, Robert J ^a   Makam, Raghavendra Charan P ^a   Yarzebski, Jorge ^a   McManus, David D ^a   Lessard, Darleen ^a   Gore, Joel M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

epidemiology; hospitalization; myocardial infarction; secondary prevention; shock, cardiogenic

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOGENIC SHOCK; EVIDENCE BASED MEDICINE; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; HOSPITAL MORTALITY; MASSACHUSETTS; MULTICENTER STUDY; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTOR; SHOCK, CARDIOGENIC; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

AGED; CHI-SQUARE DISTRIBUTION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; LOGISTIC MODELS; MASSACHUSETTS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS; SHOCK, CARDIOGENIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84962596619     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.002359     Document Type: Article

References (32)

1. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, Chen Z, Frid D, Dalen JE., Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991 325 1117 1122. doi: 10.1056/NEJM199110173251601.
2. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM., Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999 340 1162 1168. doi: 10.1056/NEJM199904153401504.
3. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J., Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009 119 1211 1219. doi: 10.1161/CIRCULATIONAHA.108.814947.
4. Reynolds HR, Hochman JS., Cardiogenic shock: current concepts and improving outcomes. Circulation 2008 117 686 697. doi: 10.1161/CIRCULATIONAHA.106.613596.
5. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH., Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999 341 625 634. doi: 10.1056/NEJM199908263410901.
6. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD, SHOCK Investigators Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006 295 2511 2515. doi: 10.1001/jama.295.21.2511.
7. Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH., Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J 2001 141 65 72. doi: 10.1067/mhj.2001.111405.
8. Fang J, Mensah GA, Alderman MH, Croft JB., Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J 2006 152 1035 1041. doi: 10.1016/j.ahj.2006.07.013.
9. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM, GRACE Investigators Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007 297 1892 1900. doi: 10.1001/jama.297.17.1892.
10. Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefèvre T, Durand E, Blanchard D, Simon T, Cambou JP, Danchin N., Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 2012 33 2535 2543. doi: 10.1093/eurheartj/ehs264.
11. Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P, AMIS Plus Registry Investigators Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 2008 149 618 626
12. Menon V, Hochman JS, Stebbins A, Pfisterer M, Col J, Anderson RD, Hasdai D, Holmes DR, Bates ER, Topol EJ, Califf RM, Ohman EM., Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J 2000 21 1928 1936. doi: 10.1053/euhj.2000.2240.
13. Goldberg RJ, Gore JM, Alpert JS, Dalen JE., Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA 1986 255 2774 2779
14. Goldberg RJ, Yarzebski J, Lessard D, Gore JM., A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999 33 1533 1539
15. Goldberg RJ, Spencer FA, Yarzebski J, Lessard D, Gore JM, Alpert JS, Dalen JE., A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol 2004 94 1373 1378. doi: 10.1016/j.amjcard.2004.07.142.
16. Floyd KC, Yarzebski J, Spencer FA, Lessard D, Dalen JE, Alpert JS, Gore JM, Goldberg RJ., A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes 2009 2 88 95. doi: 10.1161/CIRCOUTCOMES.108.811828.
17. Goldberg RJ, Gore JM, Alpert JS, Dalen JE., Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J 1988 115 761 767
18. Lindholm MG, Boesgaard S, Torp-Pedersen C, Køber L, TRACE registry study group Diabetes mellitus and cardiogenic shock in acute myocardial infarction. Eur J Heart Fail 2005 7 834 839. doi: 10.1016/j.ejheart.2004.09.007.
19. Lindholm MG, Aldershvile J, Sundgreen C, Jørgensen E, Saunamäki K, Boesgaard S., Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience. Eur J Heart Fail 2003 5 73 79
20. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso JE, Tracy CM, Woo YJ, Zhao DX, CF/AHA Task Force 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 127 529 555. doi: 10.1161/CIR.0b013e3182742c84.
21. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, ACC/AHA Task Force Members; Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 130 2354 2394. doi: 10.1161/CIR.0000000000000133.
22. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Smith SC Jr., 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999 100 1016 1030
23. Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, Ho PM, Kosiborod MN, Masoudi FA, Nallamothu BK, American College of Cardiology/American Heart Association Task Force on Performance Measures; American Academy of Family Physicians; American College of Emergency Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Cardiovascular Angiography and Interventions; Society of Hospital Medicine ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008 118 2596 2648. doi: 10.1161/CIRCULATIONAHA.108.191099.
24. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS, NRMI Investigators Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005 294 448 454. doi: 10.1001/jama.294.4.448.
25. Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, Fonarow GC., Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc 2014 3 e000590. doi: 10.1161/JAHA.113.000590.
26. Abdel-Qadir HM, Ivanov J, Austin PC, Tu JV, Dzavík V., Temporal trends in cardiogenic shock treatment and outcomes among ontario patients with myocardial infarction between 1992 and 2008. Circ Cardiovasc Qual Outcomes 2011 4 440 447. doi: 10.1161/CIRCOUTCOMES.110.959262.
27. Lindholm MG, Køber L, Boesgaard S, Torp-Pedersen C, Aldershvile J, Trandolapril Cardiac Evaluation study group Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J 2003 24 258 265
28. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, Braunwald E., The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989 14 40 46; discussion 47
29. Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, White HD, Hochman JS., Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 36 3 Suppl A 1084 1090
30. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ., Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995 26 668 674
31. Menon V, Fincke R., Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail 2003 9 35 39
32. Bangalore S, Gupta N, Guo Y, Lala A, Balsam L, Roswell RO, Reyentovich A, Hochman JS., Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 2015 128 601 608. doi: 10.1016/j.amjmed.2014.12.009.